Literature DB >> 3085984

Glycosaminoglycans of skin and urine in pseudoxanthoma elasticum: evidence for chondroitin 6-sulfate alteration.

M O Longas, P Wisch, M G Lebwohl, R Fleischmajer.   

Abstract

Abnormally elevated hyaluronic acid and dermatan sulfate were isolated from lesional skin of a patient with severe pseudoxanthoma elasticum. These glycosaminoglycans (estimated as uronic acid) surpassed the normal controls by 33.6 and 4.8 magnitudes, respectively. Urine chondroitin 6-sulfate of the same patient moved faster by electrophoresis on cellulose acetate than its counterpart isolated from urine of another four patients or from the normal controls. Hyaluronic acid and chondroitin 6-sulfate exceeded their counterparts in normal urine by 2- to 10- and 4- to 18-folds, respectively. These increments correlated with the pseudoxanthoma elasticum severity in three of the five patients studied. The data showed: the first conclusive evidence that dermatan sulfate increased in lesional skin of a patient, with severe pseudoxanthoma elasticum, who also had considerably augmented HA, alteration of the same patient's urine chondroitin 6-sulfate, and diversified urine glycosaminoglycans in pseudoxanthoma elasticum.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3085984     DOI: 10.1016/0009-8981(86)90242-1

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  7 in total

1.  Immunohistochemical staining for chondroitin sulphate and keratan sulphate. An evaluation of two monoclonal antibodies.

Authors:  S Daugaard; L Strange; T Schiødt
Journal:  Histochemistry       Date:  1991

2.  Elevated xylosyltransferase I activities in pseudoxanthoma elasticum (PXE) patients as a marker of stimulated proteoglycan biosynthesis.

Authors:  Christian Götting; Doris Hendig; Alexandra Adam; Sylvia Schön; Veronika Schulz; Christiane Szliska; Joachim Kuhn; Knut Kleesiek
Journal:  J Mol Med (Berl)       Date:  2005-08-24       Impact factor: 4.599

3.  Polymorphisms in the xylosyltransferase genes cause higher serum XT-I activity in patients with pseudoxanthoma elasticum (PXE) and are involved in a severe disease course.

Authors:  S Schön; V Schulz; C Prante; D Hendig; C Szliska; J Kuhn; K Kleesiek; C Götting
Journal:  J Med Genet       Date:  2006-03-29       Impact factor: 6.318

4.  Matrix proteins with high affinity for calcium ions are associated with mineralization within the elastic fibers of pseudoxanthoma elasticum dermis.

Authors:  M B Contri; F Boraldi; F Taparelli; A De Paepe; I P Ronchetti
Journal:  Am J Pathol       Date:  1996-02       Impact factor: 4.307

5.  New insights into the pathogenesis of pseudoxanthoma elasticum and related soft tissue calcification disorders by identifying genetic interactions and modifiers.

Authors:  Doris Hendig; Cornelius Knabbe; Christian Götting
Journal:  Front Genet       Date:  2013-06-19       Impact factor: 4.599

6.  Serum hyaluronidase aberrations in metabolic and morphogenetic disorders.

Authors:  Berta Fiszer-Szafarz; Barbara Czartoryska; Anna Tylki-Szymanska
Journal:  Glycoconj J       Date:  2005-11       Impact factor: 3.009

Review 7.  Histopathology of pseudoxanthoma elasticum and related disorders: histological hallmarks and diagnostic clues.

Authors:  Mohammad J Hosen; Anouck Lamoen; Anne De Paepe; Olivier M Vanakker
Journal:  Scientifica (Cairo)       Date:  2012-07-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.